HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Miklós Sántha Selected Research

Apolipoprotein B-100 (Apo B 100)

1/2015Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment.
10/2013Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice.
1/2012Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.
8/2009Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes.
6/2009Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice.
6/2008Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice.
10/2007Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice.
9/2006Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Miklós Sántha Research Topics

Disease

6Alzheimer Disease (Alzheimer's Disease)
01/2015 - 11/2004
4Atherosclerosis
01/2015 - 09/2006
3Amyloid Plaque
11/2013 - 01/2007
3Hypercholesterolemia
10/2013 - 09/2006
3Hyperlipidemias (Hyperlipidemia)
01/2012 - 10/2007
2Ischemia
05/2014 - 06/2009
2Hypertriglyceridemia
01/2012 - 10/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2015
1Shock
05/2014
1Brain Diseases (Brain Disorder)
10/2013
1Anoxia (Hypoxia)
04/2010
1Atherosclerotic Plaque (Atheroma)
08/2009
1Pain (Aches)
12/2008
1Heart Failure
01/2008
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2007
1Schizophrenia (Dementia Praecox)
01/2005
1Heart Diseases (Heart Disease)
11/2004

Drug/Important Bio-Agent (IBA)

8Apolipoprotein B-100 (Apo B 100)IBA
01/2015 - 09/2006
5CholesterolIBA
06/2009 - 11/2004
4Amyloid (Amyloid Fibrils)IBA
11/2013 - 09/2006
3BiglycanIBA
04/2010 - 01/2007
2Proteoglycans (Proteoglycan)IBA
04/2010 - 08/2009
2Apolipoproteins B (ApoB)IBA
01/2007 - 09/2006
1Biological Markers (Surrogate Marker)IBA
01/2015
1Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2014
1Ethanol (Ethyl Alcohol)IBA
05/2014
1HSP27 Heat-Shock ProteinsIBA
11/2013
1LDL CholesterolIBA
10/2013
1tau Proteins (tau Protein)IBA
01/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2010
1SR 144528IBA
12/2008
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
12/2008
1mu Opioid Receptors (mu Opioid Receptor)IBA
12/2008
1Lipoproteins (Lipoprotein)IBA
06/2008
1Superoxides (Superoxide)IBA
10/2007
1Peroxynitrous Acid (Peroxynitrite)IBA
10/2007
1ApolipoproteinsIBA
01/2007
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2007
1Dopamine Receptors (Dopamine Receptor)IBA
01/2005